Loading…
Treace Medical Concepts, Inc. is projected to rise to $4.93 by 2027, a +14% move from its current price of $4.32. TMCI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $4.11 | $4.32 | $4.55 | +0.07% |
| Jul 15 | $4.02 | $4.33 | $4.65 | +0.14% |
| Jul 16 | $3.96 | $4.33 | $4.73 | +0.21% |
| Jul 17 | $3.91 | $4.33 | $4.80 | +0.28% |
| Jul 18 | $3.86 | $4.33 | $4.86 | +0.34% |
| Jul 19 | $3.82 | $4.34 | $4.92 | +0.41% |
| Jul 20 | $3.79 | $4.34 | $4.97 | +0.48% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.79 | $4.34 | $4.97 | +0.48% |
| Week 2 | $3.60 | $4.36 | $5.29 | +0.97% |
| Week 3 | $3.46 | $4.38 | $5.55 | +1.45% |
| Week 4 | $3.36 | $4.40 | $5.78 | +1.94% |
| Week 5 | $3.27 | $4.43 | $6.00 | +2.43% |
| Week 6 | $3.19 | $4.45 | $6.20 | +2.93% |
| Week 7 | $3.12 | $4.47 | $6.40 | +3.42% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Treace Medical Concepts, Inc. is a medical technology company that designs, manufactures, and markets medical devices in the United States. The company offers a broad portfolio focused on bunion correction and foot/ankle surgery, including the Lapiplasty System, Nanoplasty 3D Minimally Invasive Bunion Correction System, Percuplasty Percutaneous 3D Bunion Correction System, and Adductoplasty System, among other instruments and implants for various bunion classes.
The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides and a pre-operative plan for a complete picture of the deformity and correction. The portfolio also includes SpeedMTP Rapid Compression Implant, SpeedPlate Implant Fixation Platform, SpeedPlate Micro-Quad, SpeedAkin Anatomic Compression Implant, and related tools and biologics such as Treace Allograft Wedges and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc.
was founded in 2013 and is headquartered in Ponte Vedra, Florida, operating within the Healthcare sector.
Treace Medical Concepts, Inc. (TMCI) currently trades at $4.45 with a market capitalization of $288.68M and ranks 3532. This places the asset in a mid-cap to smaller-cap segment within the market structure.
The price outlook is positive over the horizon, with the forecast showing the average price rising from $4.45 in 2026 to higher levels in subsequent years. Notably, the forecast projects an average of $11.62 by 2030, $33.56 by 2040, and $104.14 by 2050, signaling a long-term uptrend.
Forecasted upside is substantial, with ROIs of 161.2% by 2030 and 2240.1% by 2050, alongside a bullish sentiment emerging in later years. These figures illustrate a potential multi-year appreciation, albeit with the usual uncertainty and variability inherent in long-horizon projections.
A major floor 72.2% below — a decisive break under it would weaken the trend.
The nearest floor, 28.7% below — buyers have tended to step in here.
The nearest ceiling, 7.9% above — a clean break opens room to run.
A major ceiling 29.6% above — clearing it would confirm fresh momentum.
Key TMCI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TMCI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.45 | Sell | $4.40 | Sell |
| MA 10 | $4.34 | Sell | $4.34 | Sell |
| MA 20 | $4.23 | Buy | $4.16 | Buy |
| MA 50 | $3.34 | Buy | $3.53 | Buy |
| MA 100 | $2.49 | Buy | $3.14 | Buy |
| MA 200 | $3.20 | Buy | $3.53 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.69 | Neutral |
| Stoch RSI (14) | 6.27 | Buy |
| CCI (20) | 32.06 | Neutral |
| Williams %R (14) | -50.00 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -3.79 | Sell |
| Bollinger %B (20,2) | 0.60 | Neutral |
| Stochastic %K (14) | 50.00 | Neutral |
| TRIX (15) | 1.36 | Buy |
| Awesome (5,34) | 0.57 | Buy |
| Ultimate (7,14,28) | 57.55 | Neutral |
| Momentum (10) | -0.13 | Sell |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 4.50 | Sell |
| ADX (14) | 28.09 | Buy |
| ATR (14) | 0.22 | Info |
The near-term technical picture is bullish, with RSI14 at 70 and momentum supportive of upside moves. The 50-day simple moving average stands at $2.86, while the 200-day simple moving average is at $3.34, providing some upside headroom against the current price.
Support is seen at $2.53 and resistance at $4.49, framing a defined neighborhood for price action in the near term. The 30-day trading range spans from $3.12 to $6.34, indicating room for movement within a band around the current price and the nearby resistance level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.20 | $4.32 | $6.21 | 0% | Neutral | |
| $3.60 | $4.93 | $7.28 | +14% | Neutral | |
| $4.26 | $6.18 | $9.71 | +43% | Bullish | |
| $5.26 | $8.02 | $13.21 | +86% | Bullish | |
| $7.03 | $11.20 | $19.19 | +159% | Bullish | |
| $8.49 | $14.10 | $25.00 | +226% | Bullish | |
| $8.34 | $14.41 | $26.32 | +234% | Bullish | |
| $9.01 | $16.19 | $30.37 | +275% | Bullish | |
| $9.11 | $16.98 | $32.64 | +293% | Bullish | |
| $8.72 | $16.86 | $33.14 | +290% | Bullish | |
| $14.89 | $33.09 | $71.35 | +666% | Bullish | |
| $44.24 | $98.31 | $226.10 | +21.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.20 | $4.32 | $5.37 | +0.00% |
| August 2026 | $3.61 | $4.37 | $5.49 | +1.12% |
| September 2026 | $3.75 | $4.60 | $5.90 | +5.29% |
| October 2026 | $3.95 | $4.89 | $6.38 | +6.37% |
| November 2026 | $3.82 | $4.78 | $6.32 | -2.36% |
| December 2026 | $3.66 | $4.63 | $6.21 | -3.04% |
Click any year to see its month-by-month TMCI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect TMCI to range from $1.20 to $6.21 through 2026. The $4.32 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The TMCI price prediction for 2027 points to an average of $4.93 (low $3.60, high $7.28) — a potential gain of +14% on today's $4.32. A consolidation phase looks the most probable path here.
In 2028, TMCI is projected to trade between $4.26 and $9.71, averaging $6.18 — a potential gain of +43% from today's $4.32. That is up +25% on the projected 2027 average. Momentum favours further upside here.
Treace Medical Concepts, Inc.'s 2029 outlook centres on $8.02, within a $5.26 to $13.21 range. That is up +30% on the projected 2028 average. That marks a +86% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, TMCI could reach as high as $19.19, with a base case around $11.20 and support toward $7.03 — roughly +159% from $4.32. Momentum favours further upside here.
Expect TMCI to range from $8.49 to $25.00 through 2031. The $14.10 average target implies a +226% move from current prices. That is up +26% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The TMCI price prediction for 2032 points to an average of $14.41 (low $8.34, high $26.32) — a potential gain of +234% on today's $4.32. Momentum favours further upside here.
In 2033, TMCI is projected to trade between $9.01 and $30.37, averaging $16.19 — a potential gain of +275% from today's $4.32. That is up +12% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Treace Medical Concepts, Inc.'s 2034 outlook centres on $16.98, within a $9.11 to $32.64 range. That is up +5% on the projected 2033 average. That marks a +293% change versus current levels. Momentum favours further upside here.
By 2035, TMCI could reach as high as $33.14, with a base case around $16.86 and support toward $8.72 — roughly +290% from $4.32. Buyers look set to stay in control over this stretch.
Expect TMCI to range from $14.89 to $71.35 through 2040. The $33.09 average target implies a +666% move from current prices. That is up +96% on the projected 2035 average. Momentum favours further upside here.
The TMCI price prediction for 2050 points to an average of $98.31 (low $44.24, high $226.10) — a potential gain of +21.8x on today's $4.32. Buyers look set to stay in control over this stretch.
Investing $1,000 in TMCI today (≈ 231.481481 TMCI) could be worth
$22,756.04
+$21,756.04 (+2176%) by 2050 · US Dollar
Based on the average projected TMCI price of $98.31 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TMCIwould be worth at today's price.
$1,000 invested in TMCI on Jul 10, 2025 (≈ 161.030595 TMCI) would be worth
$695.65
-$304.35 (-30.4%) today · 0.70× · US Dollar
Based on a TMCI entry price of $6.21 vs. today's $4.32.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.21 | $1,026.13 | +2.6% |
| 1 month ago | $4.23 | $1,021.28 | +2.1% |
| 3 months ago | $1.81 | $2,386.74 | +138.7% |
| 6 months ago | $2.8 | $1,542.86 | +54.3% |
| 1 year ago | $6.21 | $695.65 | -30.4% |
| All time (5.0y) ago | $27.86 | $155.06 | -84.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TMCI forecast.
Our base-case forecast reaches $8.60 around 2030.
Implied market cap at $8.60: $557.91M
The multi-year forecast outlines a clear uptrend, with the average price rising from $4.45 in 2026 to $11.62 in 2030, $33.56 in 2040, and $104.14 in 2050. Calibrated ROIs expand from 0% in 2026 to 161.2% by 2030 and a striking 2240.1% by 2050, with a bullish sentiment noted from 2028 onward.
This longer horizon suggests meaningful upside potential, driven by the rising average prices in each forecast year. However, the forecast also carries uncertainty, and outcomes may differ from these estimates. The volatility implied by the forecast horizon underscores that these are projections, not guarantees, and investors should consider the broader market dynamics and risk factors.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $11.62, with a minimum of $7.17 and a maximum of $20.20, and an expected ROI of 161.2% with a BULLISH sentiment.
Forecasts indicate positive upside in several years, with an average price path rising to $11.62 by 2030 and to $104.14 by 2050, and ROIs of 161.2% in 2030 and 2240.1% in 2050. The sentiment turns BULLISH in later years, though these are estimates and not guarantees.
Yes. The 2030 forecast lists a maximum of $20.20, indicating it could reach or approach that level by 2030.
The 2040 forecast shows an average price of $33.56, with a minimum of $15.10 and a maximum of $73.73, and a BULLISH sentiment. The implied ROI for 2040 is part of a rising long-term path.
The 2050 forecast lists an average of $104.14 and a maximum of $239.51, with a 2240.1% ROI and a BULLISH sentiment, suggesting that reaching or exceeding $100 by 2050 is consistent with the forecast.
Treace Medical Concepts, Inc. Community Discussion
0Share your Treace Medical Concepts, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.